CoChat

Commentary: A dose-response relationship for radiation-induced heart disease--current issues and future prospects

McGale, P., Darby, S. C · 2008 · International Journal of Epidemiology
Cited by 35

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

There is compelling evidence that ionizing radiation can increase the risk of heart disease. An overview of 63 trials including 32 800 women with early breast cancer1 found that the death rate from heart disease in women randomized to radiotherapy was 27% higher than that for women randomized to no radiotherapy (SE 7%, 2p = 0.0001). Irradiated women in these trials received 1–20 Gy mean cardiac dose,2 depending on the technique used and the laterality of the tumour, typically in about 20 fractions. Breast cancer radiotherapy techniques have changed since many of the women in these trials were irradiated and mean cardiac doses have reduced. However, the heart still usually receives some dose. A detailed study of cardiac doses from adjuvant tangential breast cancer radiotherapy in 2006 in a major UK radiotherapy centre found that about half the women with left-sided tumours received doses of 20 Gy or more to a small part of the heart, usually including the left anterior descending coronary artery.3 In addition, most of the heart volume received >1 Gy dose from scattered irradiation in both left- and right-sided breast cancer. In this study of breast cancer patients in 2006, mean dose to the whole heart was 2.3 Gy on average for left-sided breast cancer and 1.5 Gy on average for right-sided breast cancer. The long-term implications of such doses are, as yet, unknown. Breast cancer is the commonest cancer in women, with around a million new cases diagnosed each year worldwide. Five-year survival is ∼80% in many countries and there are now many millions of breast cancer survivors. Radiotherapy has been shown to reduce the risk of recurrence and death from breast cancer. The trials have also shown that radiotherapy can reduce 15-year overall mortality following breast conserving surgery and following mastectomy in node-positive disease,1 but much uncertainty still remains regarding the long-term overall effect from modern breast cancer radiotherapy. If the relationship between cardiac radiation dose and the long-term risk of heart disease were known, then it would be possible to compare the likely long-term benefit of radiotherapy on the breast cancer with the likely long-term risk of radiation-induced heart disease, and tailor the treatment accordingly. For example, if the risk of radiation-induced heart disease were judged to be high for a particular woman, then complex radiotherapy planning techniques might be considered in order to reduce her cardiac dose. The treatment of early breast cancer illustrates the urgent need to find out more about the long-term risk of heart disease from doses of ionizing radiation in the range 0.5–5 Gy. One of the first suggestions that there might be an appreciable cardiac risk from doses of this magnitude came from the study of long-term survivors of the atomic bombings of Hiroshima and Nagasaki.4 In this population, risk of death from heart disease increased by 17% per Sv (90% CI 8–20%) following single whole body doses in the range 0–4 Sv, mostly from γ-radiation, for which 1 Sv = 1 Gy. Prompted by this finding, we carried out a systematic review of published epidemiological evidence in which we identified six further studies with doses in the range 0.5–5 Gy where there was no obvious bias or confounding and where there was reasonable power for detecting an effect similar in magnitude to that seen in the atomic bomb survivors.5 We have now updated this review and a new literature search, carried out along the same lines as previously, has identified three further published studies.6–8 A fourth study, of workers at British Nuclear Fuels plc (BNFL), has just been published.9 The BNFL study considers the relationship between mortality from heart disease and cumulative radiation dose in 42 000 monitored radiation workers employed between 1946 and 2002, and followed to 2005. It is by no means the first study of heart disease in monitored radiation workers but, apart from those carried out in Russia, the majority of other studies are based almost entirely on exposures below 0.5 Sv.5 In contrast, past radiation doses to some BNFL workers at the Sellafield site have been considerable, and an appreciable number of workers received cumulative doses of >0.5 Sv. Therefore, this study may also be informative as regards the risk of radiation-induced heart disease following doses in the range 0.5–5 Gy (or 0.5–5 Sv), and it brings the total number of such studies up to 11. The results from the 11 potentially informative studies are summarized in Table 1. Five of them, including the BNFL study, find significant positive associations between the risk of heart disease and measures of radiation dose, or reasonable proxy measures such as year of initial employment.4,,6,7,9,10 The remaining six studies, however, find no evidence of any association between radiation dose and risk of death from heart disease8,,11–16 and four of these8,,11–13 are not readily compatible with a positive association. Th

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/ije/dyn067

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 35

Metadata

Authors
McGale, P., & Darby, S. C.
Venue
International Journal of Epidemiology
Published
2008-05-01
Volume
37
Issue
3
Pages
518-523
ISSN
  • 0300-5771 (ISSN-L)
  • 1464-3685
OpenAlex
W2171684345
Cited by
35
References
3
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.